Haemophilus influenzae type b bacteria cause a variety of serious illnesses, from arthritis to meningitis to infections of the bloodstream. However, PedvaxHIB is used to prevent these conditions by "tricking" the body into producing antibodies in response to the vaccine. It is approved for use in children ages two months to six years old, but can be given to older children in certain circumstances.
What Is PedvaxHIB Used For?PedvaxHIB® (Hib vaccine) is a childhood vaccine designed for use in children ranging from two months to six years of age. It is approved to prevent invasive disease caused by the Haemophilus influenzae type b (Hib) bacteria. Invasive Hib diseases that PedvaxHIB can help prevent include:
- Bacterial meningitis (a life-threatening infection of the brain and spinal cord covering)
- Epiglottitis (a type of severe throat infection)
- Bloodstream infections
- Bone infections
- Skin infections
- Endocarditis (infection of the inner lining of the heart).
PedvaxHIB was unavailable for a while, due to problems with the manufacturing process. However, it is now available again.